GENOME ANNOUNCEMENT {#s0}
===================

*Acinetobacter baumannii* is a Gram-negative coccobacillus known for its remarkable persistence in hospital environments worldwide; it causes nosocomial infection, and reports have shown that it is potentially resistant to several antibiotics, thus limiting current therapeutic options ([@B1], [@B2]). Previous Moroccan studies have shown that, during the period of 2003 to 2016, this microorganism represented 6.94% of all bacterial infections and 9.6% of all Gram-negative bacilli ([@B3]) and that its antibiotic resistance rates increased from 23 to 76% for imipenem, 63 to 86% for ceftazidime, 41 to 52% for amikacin, and 68 to 87% for ciprofloxacin ([@B3], [@B4]).

In this study, we present the draft genome sequences of two multidrug-resistant *A. baumannii* strains, isolated from a Moroccan hospital floor, that demonstrate resistance to various antibiotics, including ticarcillin, piperacillin, ticarcillin-clavulanic acid, piperacillin-tazobactam, ceftazidime, cefepime, imipenem, gentamicin, tobramycin, amikacin, netilmicin, ciprofloxacin, tetracycline, and cotrimoxazole (but not colistin).

Genomic DNA was extracted using a DNA IQ system kit (Promega) and quantified using a NanoVue Plus spectrophotometer (Biochrom). The library of genomic DNA was prepared using a Nextera XT DNA library preparation kit (Illumina), with dual indexing adapters, and sequenced using an Illumina MiSeq sequencer with a 2 × 251-bp paired-end configuration. The sequencing generated 2,843,500 reads for ABE8_07 and 601,494 reads for ABE12_M. The sequences were trimmed and *de novo* assembled using CLC Genomics Workbench version 9.5 (Qiagen). Strain ABE8_07 comprised 187 contigs with a total length of 3,898,083 bp, an *N*~50~ of 57,519 bp, and an average contig length of 20,845 bp, while strain ABE12_M comprised 196 contigs with a total size of 3,902,530 bp, an *N*~50~ of 54,846 bp, and an average contig length of 19,911 bp. The G+C contents for ABE8_07 and ABE12_M were 38.97% and 38.95%, respectively.

The genomes were annotated using Prokka version 1.7 ([@B5]) and the Rapid Annotations using Subsystems Technology (RAST) server ([@B6]). The annotation of strain ABE8\_ 07 detected 3,657 protein-coding genes, 63 tRNA genes, and 6 rRNAs, representing 456 subsystems. The annotation of strain ABE12_M detected 3,669 protein-coding genes, 61 tRNA genes, and 3 rRNA genes, representing 453 subsystems.

Analysis of antimicrobial resistance genes by ResFinder version 2.1 ([@B7]) indicated the presence of multiple genes encoding for resistance to β-lactams (*bla*~ADC-25~, *bla*~OXA-23~, *bla*~OXA-66~, and *bla*~TEM-1D~), aminoglycosides \[*aph(3′)-VIa*, *aph \[3′\]-Ic*, *aadA1*, *aacA4*, *strA*, *strB*, and *armA*\], fluoroquinolone-aminoglycosides \[*aac(6′)Ib-cr*\], macrolide-lincosamide-streptogramin \[*msr*(E) and *mph*(E)\], sulfonamide (*sul1*), phenicol (*catB8*), and tetracycline \[*tet*(B)\] in both the genomes, except for *aadB*, which was present in ABE12_M only.
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This whole-genome shotgun project has been deposited at DDBJ/EMBL/GenBank under the accession numbers [FPKN00000000](https://www.ncbi.nlm.nih.gov/nuccore/FPKN00000000) and [FPEF00000000](https://www.ncbi.nlm.nih.gov/nuccore/FPEF00000000) for strains ABE8_07 and ABE12_M, respectively. The versions described in this article are the first versions, FPKN01000000 and FPEF01000000.

**Citation** Alouane T, Uwingabiye J, Lemnouer A, Lahlou L, Laamarti M, Kartti S, Benhrif O, El Misbahi H, Frikh M, Benlahlou Y, Bssaibis F, El Abbassi S, Kabbage S, Maleb A, Elouennass M, Ibrahimi A. 2017. First whole-genome sequences of two multidrug-resistant *Acinetobacter baumannii* strains isolated from a Moroccan hospital floor. Genome Announc 5:e00298-17. <https://doi.org/10.1128/genomeA.00298-17>.

This work was carried out under national funding from the Moroccan Ministry of Higher Education and Scientific Research (PPR program) to A.I. This work was also supported by a grant from the NIH for H3Africa BioNet to A.I.
